ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

HZNP Horizon Therapeutics Public Limited Company

116.30
0.00 (0.00%)
02 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Horizon Therapeutics Public Limited Company NASDAQ:HZNP NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 116.30 116.31 116.30 0 01:00:00

Horizon Therapeutics plc to Present at the Cowen and Company 40th Annual Health Care Conference

18/02/2020 1:30pm

Business Wire


Horizon Therapeutics Pub... (NASDAQ:HZNP)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Horizon Therapeutics Pub... Charts.

Horizon Therapeutics plc (Nasdaq: HZNP) today announced that the Company will participate in the following conference in March:

Cowen and Company 40th Annual Health Care Conference

  • Date: Tuesday, Mar. 3, 2020
  • Presentation Time: 12 p.m. ET
  • Location: Boston

The conference presentation will be webcast live and may be accessed by visiting Horizon's website at http://ir.horizontherapeutics.com. A replay of the webcast will be available for the event.

About Horizon

Horizon is focused on researching, developing and commercializing medicines that address critical needs for people impacted by rare and rheumatic diseases. Our pipeline is purposeful: we apply scientific expertise and courage to bring clinically meaningful therapies to patients. We believe science and compassion must work together to transform lives. For more information on how we go to incredible lengths to impact lives, please visit www.horizontherapeutics.com, follow us @HorizonNews on Twitter, like us on Facebook or explore career opportunities on LinkedIn.

Investors: Tina Ventura Senior Vice President, Investor Relations investor-relations@horizontherapeutics.com

Ruth Venning Executive Director, Investor Relations investor-relations@horizontherapeutics.com

U.S. Media: Geoff Curtis Executive Vice President, Corporate Affairs & Chief Communications Officer media@horizontherapeutics.com

Ireland Media: Ray Gordon Gordon MRM ray@gordonmrm.ie

1 Year Horizon Therapeutics Pub... Chart

1 Year Horizon Therapeutics Pub... Chart

1 Month Horizon Therapeutics Pub... Chart

1 Month Horizon Therapeutics Pub... Chart

Your Recent History

Delayed Upgrade Clock